NanoViricides News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.10.22	EQS-News: This Company Is Looking For A Monkeypox Drug As City Investigates Deaths (EQS Group)
19.09.22	EQS-News: NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly (EQS Group)
17.08.22	Pre-market Movers: HIL, BBBY, JCSE, SAVA, MX… (RTTNews)
10.08.22	DGAP-News: Monkeypox Is Popping Up In Places It Shouldnt But NanoViricides Says It May Have A Solution (EQS Group)
26.05.22	Pre-market Movers: NTNX, WKME, SNOW, ISPC, NNVC… (RTTNews)
15.11.21	Pre-market Movers: CREX, BTB, EYPT, OXBR, MICT… (RTTNews)
05.10.21	NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference (PR Newswire)
27.09.21	Pre-market Movers: PHCF, PALT, BBIG, USEG, SNTG… (RTTNews)
22.09.21	Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug (PR Newswire)
15.09.21	Pre-market Movers: NXTD, KAVL, SONM, MITC, BTCS… (RTTNews)
14.09.21	NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development (PR Newswire)
03.09.20	Pre-market Movers In Healthcare Sector: SNSS, NNVC, STRO, FLGT, LPCN... (RTTNews)
03.09.20	AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch (RTTNews)
08.07.20	Pre-market Movers In Healthcare Sector: NNVC, BCRX, XENT, VVUS… (RTTNews)
08.07.20	Stock Alert: NanoViricides Stock Up 50% In Early Trade (RTTNews)
13.05.20	ARPO Soars, GNFT's NASH Study Fails, Moderna's COVID-19 Vaccine On Fast Track (RTTNews)
12.05.20	Stock Alert: NanoViricides Stock Up 37% In Premarket (RTTNews)
12.03.20	Stocks Double And Tripled In Value From Coronavirus (RTTNews)
06.03.20	Stock Alert: Coronavirus Panic Propels NanoViricides Shares In After Hours (RTTNews)
27.02.20	Fighting The Deadly Coronavirus (RTTNews)
22.10.19	Today's Top 6 Gainers In Healthcare Sector (CNST, APRE, PETS…) (RTTNews)
03.06.19	NanoViricides Gets Favorable FDA Comments On Pre-IND Application; Stock Surges (RTTNews)
22.05.18	NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and It Is Scaling Up Production of Certain Herpecide Program Drug Candidates (PR Newswire)
09.04.18	NanoViricides Reports Good Safety Profile of Topical Dermal Drug Candidates; Dr. Diwan, President, Will Present at the MicroCap Conference in New York City Today (PR Newswire)
19.03.18	NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the University of Wisconsin (PR Newswire)
21.02.18	NanoViricides Files Quarterly Report for Period Ending December 31, 2017 (PR Newswire)
06.12.17	Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates (PR Newswire)
20.11.17	NanoViricides Files Quarterly Report for Period Ending September 30, 2017 (PR Newswire)
06.11.17	NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November 10th at the Annual Meeting of the Ocular Microbiology and Immunology... (PR Newswire)
26.10.17	Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement with SUNY Upstate Medical Center (PR Newswire)
17.10.17	NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of the Ocular Microbiology and Immunology Group (OMIG) of the American... (PR Newswire)
11.09.17	NanoViricides, Inc. Announces its CEO Dr. Seymour to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 12, 2017 (PR Newswire)
10.07.17	NanoViricides Reports Its Drug Candidates Significantly Reduced the Extent of Shingles Virus Infection of Human Skin (PR Newswire)
26.06.17	NanoViricides' Poster "Novel Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented Today at the 2017 Annual Meeting of American Society of Virology (PR Newswire)
20.06.17	NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology (PR Newswire)
13.06.17	NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York City (PR Newswire)
12.06.17	Global Chatbots Market Demonstrates Worth of 6 Billion USD at 37% of CAGR by 2023 (PR Newswire)
06.06.17	NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell Culture Studies (PR Newswire)
16.05.17	NanoViricides Files Quarterly Report for Period Ending 2017-03-31 (PR Newswire)
26.04.17	NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Company Says it is Close to Declaring a Clinical Candidate for the Treatment... (PR Newswire)
13.02.17	NanoViricides Reports the Company's Director Dr. Boniuk Converted Series B Debenture to Equity Effectively Raising $5M in New Equity for the Company (PR Newswire)
01.12.16	NanoViricides Publishes a Letter from the CEO to Shareholders on its Website (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	49.89	0.83 %	K V
Geberit	528.40	0.61 %	K V
Part Grp Hldg	1’270.50	0.36 %	K V
CieFinRichemont	121.55	0.29 %	K V
Lonza Grp	521.80	0.27 %	K V
Givaudan	3’854.00	-0.36 %	K V
Swiss Re	129.55	-0.38 %	K V
Nestle	76.32	-0.42 %	K V
Kuehne+Nagel Int	209.30	-0.43 %	K V
Swiss Life Hldg	715.60	-0.83 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu NanoViricides Inc

Aktien Top/Flop

Meistgelesene Nachrichten